Applied DNA Sciences, Inc. Climbs AGAIN!!!!
OTC.BB:APDN
It’s that time again to give you an update
on APDN!
Steamrolling through previous known
resistances, APDN continues its
pursuit for higher highs. Applied DNA Sciences, Inc. knows the endless
opportunities in the biotechnology sector and has responded by positioning
itself for exponential growth, both technically and fundamentally.
After an innovative approach to the
commercialization of their patented technology, APDN refocused their business development and obtained a recent
series of anticounterfeiting contract wins in the cotton fabric and
cash-in-transit businesses described in a research report by Imperial Capital, LLC.
With over a 20% gain per share in 5 days
and extreme volume pick-up, it’s difficult to estimate and predict where APDN’s stock can go from here!!!
Based upon last year’s numbers, the market
saw APDN’s shares rise from $0.04 to
$0.21 in a few short months. APDN’s
current and potential shareholders should be aware of this investment and the
endless possibilities for this biotech company.
Click below to see this month’s past chart
progression as APDN has and is being
reconsidered by many investors:
http://bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=apdn&sid=0&o_symb=apdn&freq=1&time=4
About
Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc. (OTC.BB:APDN) is a provider of
botanical DNA based security and authentication solutions that can help protect
products, brands and intellectual property of companies, governments and
consumers from theft, counterfeiting, fraud and diversion. SigNature DNA and
BioMaterial Genotyping, the Company’s principal anti-counterfeiting and product
authentication solutions, can be used in a range of industries, including
cash-in-transit (transport and storage of banknotes), textiles and apparel,
identity cards and other secure documents, pharmaceuticals, wine and luxury
consumer goods. Check out www.adnas.com for
more information on the Management Team and latest News Releases.
YOU COULD BE A PART OF SOMETHING GREAT . . .
We strongly encourage you
to always do your own research before investing and stay tuned for further
updates on APDN along with other
companies on our market radar!!!
Information from Last Night:
OUR ANNOUNCEMENT & SPECIAL EVENING ALERT:
APDN.ob has pulled back to STRONG SUPPORT!!!
Applied DNA Sciences, Inc. (OTC.BB:APDN) saw a bloody day in the
market and is now sitting @ SUPPORT near .05!!!!
When comparing this chart set up and
timeframe to previous moves, APDN may seems quite attractive at this level.
Just last week, many savvy traders were
able to enjoy profits of 15%, 20% or even 30% from trading APDN.
APDN has now pulled back to support and
that time may come again for our traders & long term investors.
Remember to look at the past and take a
lesson from the history books. There was “Blood in the Streets” Today!!!
It’s that time again to give you
updates on APDN!
The Biotechnology industry emerged in the
1970’s that mostly focused on a new recombinant DNA practice. Since then this
sector has proven to be quite lucrative and has grown exponentially. Scientists
all over the world have been inching closer and closer to the solutions that
our modern world needs.
The Prices Investors Forget . . .
The 3 largest Biotechnology companies are
Amgen, Inc (NASDAQ:AMGN), Gilead
Sciences, Inc. (NASDAQ:GILD), and
Celgene Corporation (NASDAQ:CELG).
Before becoming industry leaders in terms of market cap, break through
accomplishment and industry innovation, company began trading as penny stocks,
just like APDN is doing.
FACTS!
Amgen,
Inc.
NASDAQ:AMGN
Market
Cap: 49.8B
July 15, 1983 Open: $0.028
July
23, 2010 Open:
$53.15
"Within
their first 5 years of being public, AMGN was still trading under
$1.00."
Gilead
Sciences, Inc.
NASDAQ:GILD
Market
Cap: 29.6B
July 17, 1992 Open: $0.81
July
23, 2010 Open:
$33.71
"Within
their first 3 years of being public, GILD was still trading below $1.00."
Celgene
Corporation
NASDAQ:CELG
Market
Cap: 23.9B
July 22, 1988 Open: $0.74
July
23, 2010 Open:
$52.29
"Within
their first 8 years of being public, CELG was still trading under
$1.00."
Applied DNA Sciences, Inc. (OTC.BB:APDN) is a Micro Cap company
with similar goals and aspirations as their fellow industry leaders. Their
barrier and according to Imperial
Capital, LLC’s research report “the question is whether DNA (botanical or
otherwise) marking can be made commercially applicable to a wide range of
anticounterfeiting technologies.” The report continues to explain that APDN “has developed and is currently
working on a “biomaterial genotyping” platform using the genomic DNA present in
natural materials, to assure originality and quality, warranty decisions, and
to aid customs officials.”
APDN has already shown strong market support through their efforts to
change the face of field applied DNA as they have already acquired 2 contracts
and have plans to expand.
About
Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc. (OTC.BB:APDN) is a provider of
botanical DNA based security and authentication solutions that can help protect
products, brands and intellectual property of companies, governments and
consumers from theft, counterfeiting, fraud and diversion. SigNature DNA and
BioMaterial Genotyping, the Company’s principal anti-counterfeiting and product
authentication solutions, can be used in a range of industries, including
cash-in-transit (transport and storage of banknotes), textiles and apparel,
identity cards and other secure documents, pharmaceuticals, wine and luxury
consumer goods. Check out www.adnas.com for
more information on the Management Team and latest News Releases.
WHAT ARE YOU GOING TO SAY ABOUT APDN 20 YEARS FROM NOW!?
We strongly encourage you
to always do your own research before investing and stay tuned for further
updates on APDN along with other
companies on our market radar!!!
Manage your subscription
